Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?

The Immune Landscape of Cancer

Vésteinn Thórsson, David L. Gibbs, Scott D. Brown et al. · Immunity · 2018 · 6.2K citations · Full text

Medicine, Immunology, Oncology +17

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Roberto Salgado, Carsten Denkert, Sandra Demaria et al. · Annals of Oncology · 2014 · 3.1K citations · Full text

Medicine, Immunology, Oncology +16

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

Carsten Denkert, Sibylle Loibl, Aurelia Noske et al. · Journal of Clinical Oncology · 2009 · 1.8K citations

Life Sciences, Immunology, Oncology +17

Tumor-Infiltrating CD8⁺Lymphocytes Predict Clinical Outcome in Breast Cancer

Sahar Mahmoud, Emma C. Paish, Desmond G. Powe et al. · Journal of Clinical Oncology · 2011 · 1.4K citations · Full text

Life Sciences, Immunology, Oncology +17

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

Gaynor J. Bates, Stephen B. Fox, Han Cheng et al. · Journal of Clinical Oncology · 2006 · 1.2K citations

Life Sciences, Immunology, Oncology +17